Skip to main content

Rohit Bhatheja, MD, FACC, FSCAI

Rohit Bhatheja, MD, FACC, FSCAI

Medical Director, Cardiologist

Cardiovascular

Rohit Bhatheja

Overview

Rohit Bhatheja, MD, FACC, is an award-winning cardiologist with board certification in cardiovascular disease, interventional cardiology and internal medicine. As a member of the esteemed AdventHealth Medical Group cardiology team and part of the AdventHealth Cardiovascular Institute, he consults with patients at his offices in Celebration and Orlando. He also serves as Medical Director of AdventHealth’s Cardiac Care Unit. A leading physician and clinical investigator, he has been honored with awards from the National Institutes of Health, American College of Physicians and Cleveland Clinic Foundation. Dr. Bhatheja graduated from Maulana Azad Medical College in New Delhi, India prior to undertaking his residency training at the Cleveland Clinic in Ohio and his advanced training as an Interventional Fellow in cardiovascular medicine, peripheral vascular, structural heart and carotid interventions at the University of Kentucky.

Articles

Novel Micro Crown Orbital Atherectomy for Severe Lesion Calcification Coronary Orbital Atherectomy System Study (COAST)

CIRCULATION-CARDIOVASCULAR INTERVENTIONS

2020

A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism The SEATTLE II Study

JACC-CARDIOVASCULAR INTERVENTIONS

2015

Percutaneous Transcatheter Closure of the Aortic Valve

ANNALS OF THORACIC SURGERY

2015

Education & Training

Education

Maulana Azad Medical College, New Delhi, India

Residency

Cleveland Clinic Foundation

Fellowship

University of Kentucky Albert B. Chandler Hospital

Specialty

Cardiology

Board Certifications

American Board of Internal Medicine

Associated Clinical Trials

NCT04248868

Recombinant tPA by Endovascular Administration for the treatment of Submassive pulmonary embolism using pharmaco-mechanical Catheter directed thrombolysis for the redUction of thrombus burdEn - The RESCUE Study

Icon for trial | THRO-CLIN-2019-01 Recombinant tPA by Endovascular Administration for the treatment of Submassive pulmonary embolism using pharmaco-mechanical Catheter directed thrombolysis for the redUction of thrombus burdEn - The RESCUE Study

This study is currently enrolling.

You are being invited to take part in this research study because you have been recently diagnosed with a blood clot in your lung(s) and require treatment to stop the clot from getting bigger and or to prevent more clots ...